Baillie Gifford & Co
ZY

Baillie Gifford & Co’s Zymergen Inc. Common Stock ZY Stock Holding History

Baillie Gifford & Co’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,821,956
Closed -$7.84M – 495
2022
Q3 		$7.84M Hold
2,821,956
– – 0.01% 228
2022
Q2 		$3.47M Hold
2,821,956
– – ﹤0.01% 255
2022
Q1 		$8.15M Hold
2,821,956
– – 0.01% 241
2021
Q4 		$18.9M Hold
2,821,956
– – 0.01% 223
2021
Q3 		$37.2M Hold
2,821,956
– – 0.02% 203
2021
Q2 		$113M Buy
+2,821,956
New +$111M 0.06% 148

Baillie Gifford & Co's ZY Position: Q4 2022 in Review

Baillie Gifford & Co sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 2,821,956 shares — an estimated $7.84M sold.

Baillie Gifford & Co first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $113M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Baillie Gifford & Co reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Baillie Gifford & Co sold 2,821,956 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $7.84M.
  • Baillie Gifford & Co first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Baillie Gifford & Co's Zymergen Inc. Common Stock position peaked at $113M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Baillie Gifford & Co's 13F filing for Q4 2022, filed 24 Jan 2023.